Galmed Pharmaceuticals Ltd. buy Barclays PLC
Start price
09.05.24
/
50%
€0.40
Target price
09.05.25
€78.88
Performance (%)
1516.16%
Price
19.09.24
€6.40
Summary
This prediction is currently active. With a performance of 1516.16% the BUY prediction by Barclays_PLC is a big success. This prediction currently runs until 09.05.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Galmed Pharmaceuticals Ltd. | - | - |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Barclays_PLC for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Barclays PLC from $83.00 to $85.00. They now have an "overweight" rating on the stock.
Ratings data for GMED provided by MarketBeat
Stopped prediction by Barclays_PLC for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.27
08.08.24
08.08.24
€85.19
08.08.25
08.08.25
2270.37%
19.09.24
19.09.24